Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Analysis of the association of the PRDM12 gene with pain sensitivity in individuals with psychoactive substance dependence

https://doi.org/10.14412/2074-2711-2020-1-27-32

Full Text:

Abstract

Early diagnosis of susceptibility to psychoactive substance (PAS) use and addiction is a pressing problem of addictology. The development of PAS dependence involves a reward system that also plays a key role in the modulation of nociception. The PRDM12 gene associated with congenital insensitivity to pain is involved in neurogenesis and affects the properties of nerve cells.
Objective: to comparatively assess pain sensitivity in mental and behavioral disorders caused by the use of PASs in healthy individuals and subjects with their occasional uses according to the genotype of rs10121864 in the PRDM12 gene.
Patients and methods. Examinations were made in 103 patients with addiction to PAS (F1x.2), in 114 apparently healthy individuals (a control group) and in 36 subjects who occasionally used PASs (a risk group). The pain sensitivity threshold and pain tolerance were determined by tensoalgometry; a subjective assessment of pain thresholds was made using a visual analogue scale. Genotyping was performed using the PRDM12 rs10121864 polymorphism.
Results and discussion. The distribution of the genotypes of PRDM12 rs101218 was statistically significantly different in the comparison groups. Odds ratio (OR) calculation showed that in the subjects who occasionally used PASs, the risk of their dependence was several times greater than that in carriers of the mutant A allele (OR, 2.52; 95% confidence interval (CI), 1.42–4.50) of rs10121864 and its homozygous genotype AA (OR, 6.66; 95% CI, 1.50–29.54) and in those of alternative genotypes. The PRDM12 was also found to be associated with the parameter of subjective assessment of pain sensitivity in PAS-dependent subjects. Thus, this parameter was significantly lower in the carriers of the mutant A allele than in those of the GG genotype.
Conclusion. The A allele and AA genotype of PRDM12 rs10121864 were established to be associated with the risk of PAS dependence and with the parameter of subjective perception of the upper pain threshold.

About the Authors

E. G. Poltavskaya
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
4, Aleutskaya St., Tomsk 634014



D. N. Savochkina
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
4, Aleutskaya St., Tomsk 634014



References

1. Smirnov AV. Predisposition to addictive behavior in the structure of integral individuality. Psikhopedagogika v pravookhranitel'nykh organakh. 2010;(2):44–9. (In Russ.).

2. Furmanov IA, Sizanov AN, Khriptovich VA. Profilaktika narushenii povedeniya v uchrezhdeniyakh obrazovaniya: uchebnometodicheskoe posobie [Prevention of disorders of behavior in educational institutions: Educational-methodical manual]. Minsk: RIVSh; 2011. 250 p.

3. Vnukov VV, Chernikova IV, Milyutina NP, et al. Molecular and cellular mechanisms of opium addiction. Zhurnal fundamental'noi meditsiny i biologii. 2013;(3):4–12. (In Russ.).

4. Gurov DYu, Tumanov VP, Smirnov AV, et al. Morphological changes of neurons of supraoptic nuclei of hypothalamus of rats predisposed to alcohol dependence. Sovremennye problemy nauki i obrazovaniya. 2019;(2):163. (In Russ.).

5. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010 Jan; 35(1):217-38. doi: 10.1038/npp.2009.110.

6. Clarke TK, Krause K, Li T, Schumann G. An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population. Addict Biol. 2009 Jul;14(3):366-70. doi: 10.1111/j.1369-1600.2009.00151.x. Epub 2009 Mar 5.

7. Koob GF. Neurocircuitry of alcohol addiction: synthesis from animal models. Handb Clin Neurol. 2014;125:33-54. doi: 10.1016/B978-0-444-62619-6.00003-3.

8. Belin D, Everitt BJ. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron. 2008 Feb 7;57(3):432-41. doi: 10.1016/j.neuron.2007.12.019.

9. Wise RA. The brain and reward. In: Liebman JM, Cooper SJ, editors. The neuropharmacological basis of reward. Oxford: Clarendon; 1989. P. 377–424.

10. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005 Nov;8(11):1481-9.

11. Sesack SR, Grace AA. Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology. 2010 Jan;35(1): 27-47. doi: 10.1038/npp.2009.93.

12. Bailey KP. The brain's rewarding system & addiction. J Psychosoc Nurs Ment Health Serv. 2004 Jun;42(6):14-8.

13. Lelevich VV, Kurbat MN, Lelevich SV. Neurotransmitter mechanisms of opiate addiction (literature review). Zhurnal GrGMU. 2006;(3):12-5. (In Russ.).

14. Cohen JY, Haesler S, Vong L, et al. Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature. 2012 Jan 18;482(7383):85-8. doi: 10.1038/nature10754.

15. Mitsi V, Zachariou V. Modulation of pain, nociception, and analgesia by the brain reward center. Neuroscience. 2016 Dec 3;338:81-92. doi: 10.1016/j.neuroscience.2016.05.017. Epub 2016 May 14.

16. Nevidimova TI, Batukhtina EI, Vetlugina TP, et al. Association of Cytokine Production with Hormone Level and Sensory Responses during the Formation of Psychoactive Drug Addiction in Men. Bull Exp Biol Med. 2015 Oct;159(6):768-71. doi: 10.1007/s10517-015-3071-x. Epub 2015 Oct 31.

17. Chen YC, Auer-Grumbach M, Matsukawa S, et al. Transcriptional regulator PRDM12 is essential for human pain perception. Nat Genet. 2015 Jul;47(7):803-8. doi: 10.1038/ng.3308. Epub 2015 May 25.

18. Hohenauer T, Moore AW. The Prdm family: expanding roles in stem cells and development. Development. 2012 Jul;139(13):2267-82. doi: 10.1242/dev.070110.

19. Cortes D, Holt R, de Knegt VE. Hormonal aspects of the pathogenesis and treatment of cryptorchidism. Eur J Pediatr Surg. 2016 Oct; 26(5):409-417. Epub 2016 Sep 19.

20. Shirane K, Kurimoto K, Yabuta Y, et al. Global landscape and regulatory principles of DNA methylation reprogramming for germ cell specification by mouse pluripotent stem cells. Dev Cell. 2016 Oct 10;39(1):87-103. doi: 10.1016/j.devcel.2016.08.008. Epub 2016 Sep 15.

21. Kobayashi T, Zhang H, Tang WWC, et al. Principles of early human development and germ cell program from conserved model systems. Nature. 2017 Jun 15;546(7658):416-420. doi: 10.1038/nature22812. Epub 2017 Jun 7.

22. Dickinson ME, Flenniken AM, Ji X, et al. High-throuput discovery of novel developmental phenotypes. Nature. 2016 Sep 22;537(7621): 508-514. doi: 10.1038/nature19356. Epub 2016 Sep 14.

23. Smagulova F, Brick K, Pu Y, et al. The evolutionary turnover of recombination hot spots contributes to speciation in mice. Genes Dev. 2016 Feb 1;30(3):266-80. doi: 10.1101/gad.270009.115.

24. Kinameri E, Inoue T, Aruga J, et al. Prdm proto-oncogene transcription factor family expression and interaction with the Notch-Hes pathway in mouse neurogenesis. PLoS One. 2008; 3(12):e3859. doi: 10.1371/journal.pone.0003859. Epub 2008 Dec 3.

25. Saitou M, Kagiwada S, Kurimoto K. Epigenetic reprogramming in mouse preimplantation development and primordial germ cells. Development. 2012 Jan;139(1):15-31. doi: 10.1242/dev.050849.

26. Yang CM, Shinkai Y. Prdm12 is induced by retinoic acid and exhibits anti-proliferative properties through the cell cycle modulation of P19 embryonic carcinoma cells. Cell Struct Funct. 2013;38(2):197-206. Epub 2013 Jul 12.

27. Nagy V, Cole T, Van Campenhout C, et al. The evolutionarily conserved transcription factor PRDM12 controls sensory neuron development and pain perception. Cell Cycle. 2015; 14(12):1799-808. doi: 10.1080/15384101.2015.1036209.

28. Meehan TF, Conte N, West DB, et al. Disease model discovery from 3328 gene knockouts by the international mouse phenotyping consortium. Nat Genet. 2017 Aug;49(8): 1231-1238. doi: 10.1038/ng.3901. Epub 2017 Jun 26.

29. Bokhan NA, Mandel' AI, Ivanova SA, et al. Old and new problems of narcology in the context of interdisciplinary research. Voprosy narkologii. 2017;(1):26–62. (In Russ.).

30. Fedorenko OY, Golimbet VE, Ivanova SА, et al. Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium. Mol Psychiatry.2019 Aug;24(8):1099-1111. doi: 10.1038/s41380-019-0354-z. Epub 2019 Jan 21.

31. Nevidimova TI, Bokhan NA, Kokonova DN. Method of quantitative assessment of individual pain thresholds. The patent for the invention № 2342063. Registered in The state register of inventions 27.12.2008

32. Savochkina DN, Poltavskaya EG. Assessment of psychophysiological characteristics and polymorphism of the SCN9A gene in the formation of addictive behavior. Sibirskii vestnik psikhiatrii i narkologii. 2018;(4):11–5. (In Russ.).

33. Kelley AE, Berridge Kent C. The neuroscience of natural rewards: Relevance to addictive drugs. J Neurosci. 2002 May 1;22(9):3306-11.

34. Blum K, Gold MS. Reward circuitry dopaminergic activation regulates food and drug craving behavior. Curr Pharm Des. 2011;17(12): 1158-67.

35. Miller NS, Gold MS. Opiate prescription medication dependence and pain perceptions. J Addict Dis. 2007;26 Suppl 1:65-71. doi: 10.1300/J069v26S01_07.

36. Aniskin DB, Fink E, Prosser J, et al. The effect of pain on stroop performance in patients with opiate dependence in sustained remission. J Addict Med. 2011 Mar;5(1):50-6. doi: 10.1097/ADM.0b013e3181d77c07.

37. Compton P, Canamar CP, Hillhouse M, et al. Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy. J Pain. 2012 Apr;13(4):401-9. doi: 10.1016/j.jpain.2012.01.001. Epub 2012 Mar 15.

38. Woller SA, Moreno GL, Hart N, et al. Analgesia or addiction?: implications for morphine use after spinal cord injury. J Neurotrauma. 2012 May 20;29(8):1650-62. doi: 10.1089/neu.2011.2100. Epub 2012 Apr 2.


For citation:


Poltavskaya E.G., Savochkina D.N. Analysis of the association of the PRDM12 gene with pain sensitivity in individuals with psychoactive substance dependence. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(1):27-32. https://doi.org/10.14412/2074-2711-2020-1-27-32

Views: 138


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)